Pfizer doses its first patient in Phase 2/3 trial for COVID-19 daily pill
[ad_1] Pfizer revealed on Wednesday that it gave its first dose to a patient in its Phase 2/3 clinical trial examining the effectiveness of an orally administered drug designed to fight COVID-19. CEO Albert Bourla wrote on Wednesday evening on Twitter that “success against COVID19 will likely require both vaccines [and] treatments ”and said the … Read more